TP53 and ovarian cancer: Differently than observed in A549 or HCC 827 and H1299 and H358 cells, the human ovary cancer cell lines SK-OV-3 and A2780 did not respond to cisplatin and metformin combination, independently of P53 status (Supplementary Figure 5).